SCHEMBL12310405

SCHEMBL12310405

N#C/C(=C\C=C\N1CCCCC1)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.46
▸ MAOB P27338 2/20 0.38
▸ SLC16A3 O15427 2/20 0.36
▸ SLC16A1 P53985 2/20 0.36
▸ ALDH1A1 P00352 6/20 0.36
▸ MCL1 Q07820 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ HTT P42858 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ POLB P06746 1/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CASP3 P42574 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SENP8 Q96LD8 1/20 0.33
▸ SENP7 Q9BQF6 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14629850 1.00 KMT2A (0.46) KMT2AMAOBSLC16A3SLC16A1ALDH1A1
SCHEMBL23140678 0.85 RECQL (0.50) KMT2AALDH1A1LMNAMAPTHTT
SCHEMBL20805917 0.85 RECQL (0.50) KMT2AALDH1A1LMNAMAPTHTT
SCHEMBL23140679 0.85 RECQL (0.50) KMT2AALDH1A1LMNAMAPTHTT
SCHEMBL12310408 0.80 RECQL (0.49) KMT2AMAOBSLC16A3SLC16A1ALDH1A1
SCHEMBL4544807 0.78 RECQL (0.50) KMT2ASLC16A1ALDH1A1LMNAMAPT
SCHEMBL8322342 0.77 KMT2A (0.33) KMT2AMAOBALDH1A1LMNAMAPT
SCHEMBL11333089 0.77 KMT2A (0.33) KMT2AMAOBALDH1A1LMNAMAPT
SCHEMBL8322347 0.77 KMT2A (0.33) KMT2AMAOBALDH1A1LMNAMAPT
SCHEMBL15761690 0.76 MCL1 (0.38) KMT2AMAOBALDH1A1MCL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2734180-B1 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES OREAL (FR) 2021-03-31 — — EP claimed
EP-2734180-B1 COSMETIC AND/OR DERMATOLOGICAL COMPOSITION CONTAINING A MEROCYANINE DERIVATIVE COMPRISING SPECIFIC POLAR GROUPS CONSISTING OF HYDROXYL- AND ETHER-FUNCTIONALITIES OREAL (FR) 2021-03-31 — — EP disclosed
EP-2734499-B1 MEROCYANINE DERIVATIVES BASF SE (DE) 2020-06-24 — — EP disclosed
US-20150284330-A1 COMPOSITION COMPRISING A DIBENZOYLMETHANE SCREENING AGENT AND A MEROCYANINE DICYANO OR CYANOACETATE DERIVATIVE; METHOD FOR THE PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE SCREENING AGENT OREAL (FR) 2015-10-08 — — US disclosed
US-8961941-B2 Composition comprising a dibenzoylmethane screening agent and a merocyanine dicyano or cyanoacetate derivative; method for the photostabilization of the dibenzoylmethane screening agent L'OREAL (FR) 2015-02-24 — — US disclosed
US-20130064871-A1 COMPOSITION COMPRISING A DIBENZOYLMETHANE SCREENING AGENT AND A MEROCYANINE DICYANO OR CYANOACETATE DERIVATIVE; METHOD FOR THE PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE SCREENING AGENT L'OREAL (FR) 2013-03-14 — — US disclosed
EP-2547314-A2 COMPOSITION COMPRISING A DIBENZOYLMETHANE SCREENING AGENT AND A MEROCYANINE DICYANO OR CYANOACETATE DERIVATIVE; METHOD FOR THE PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE SCREENING AGENT L'Oréal (FR) 2013-01-23 — — EP disclosed
US-20110229662-A1 Polymer film, production method for the film, and retardation film, polarizing plate and liquid-crystal display device having the film FUJIFILM CORPORATION (JP) 2011-09-22 — — US disclosed
US-20110220843-A1 POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND FUJIFILM CORPORATION (JP) 2011-09-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130064871-A1 COMPOSITION COMPRISING A DIBENZOYLMETHANE SCREENING AGENT AND A MEROCYANINE DICYANO OR CYANOACETATE DERIVATIVE; METHOD FOR THE PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE SCREENING AGENT DDT, PCCA, DDC KMT2A 1784/4885MAOB 1806/4885SLC16A3 259/4885
US-20110220843-A1 POLYMER FILM, ULTRAVIOLET ABSORBER, MEROCYANINE COMPOUND AND PROCESS FOR PREPARING MEROCYANINE COMPOUND HAMP, CRY1, CRY2 KMT2A 1571/4885MAOB 505/4885SLC16A3 615/4885
US-20150284330-A1 COMPOSITION COMPRISING A DIBENZOYLMETHANE SCREENING AGENT AND A MEROCYANINE DICYANO OR CYANOACETATE DERIVATIVE; METHOD FOR THE PHOTOSTABILIZATION OF THE DIBENZOYLMETHANE SCREENING AGENT DDT, PCCA, DDC KMT2A 1784/4885MAOB 1806/4885SLC16A3 259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback